News

The agreements concern both the distribution rights for MultiSynTech’s systems and the establishment of a joint development project. The agreements with MultiSynTech will grant Biotage distribution rights for

“Gen-Probe posted strong financial results in the fourth quarter of 2008, driven by healthy growth in both clinical diagnostics and blood screening sales,” said Hank Nordhoff, the company’s

The trial currently conducted in the UK is investigating the safety and efficacy of Sanofi Pasteur’s Clostridium difficile (CDI) candidate vaccine. While the target indication for the vaccine

The current Phase I trial is the first time CB-183,315 has been given to humans and is designed to evaluate the safety and pharmacokinetics of single escalating oral

Dr Nichols previously served as regional chairman, medical director, and director of hematopathology of the Bon Secours Richmond Regional Laboratory System, and is a past president of the

Under the companies’ collaboration agreement, Curis will receive a $6 million cash payment from Genentech following initiation of this pivotal trial. Genentech expects to evaluate GDC-0449 in approximately

The BioMask is said to be the first in a series of new products in Filligent’s anti-microbial personal care range, BioFriend, to be launched during 2009. By complying

Based in Manchester, England, Mr Kelly will be responsible for introducing RainDance’s RainStorm technology platform to Europe. Mr Kelly will work with thought leaders in genomics research to

Quadramet (153 Samarium-lexidronam) is a radioactive medication that targets the bone, specifically bone cancer, and is used to treat pain caused by cancer that has metastasized or spread